1. Venkataramanan R., Jain A., Cadoff E. et al. (1990): Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant. Proc., 22 (suppl 1) 52–56.
2. Christians U., Kruse C., Kownatzki R. et al. (1991): Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. Transplant. Proc., 23 940–941.
3. Shah I.A., Whiting P.H., Omar G., Thomson A.W., Burke M.D. (1991): Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. Transplant. Proc., 23, 2783–2785.
4. Sattler M., Guengerich F.P., Yun C.H., Christians U., Sewing F.K. (1992): Cytochrome P-450 3A enzymes are responsible for biotransformation of FK 506 and rapamycin in man and rat. Drug Metab. Dispos., 20, 753–761.
5. Stiff D.D., Venkataramanan R., Tara T.N.V. (1992): Metabolism of FK 506 in differentially induced rat liver microsomes. Res. Commun. Chem. Pathol., 78, 121–124.